Pulse Biosciences, Inc.

PLSENASDAQHealthcare● Active

$24.84

$-0.49(-1.93%)

Market Cap$1.7B

P/E Ratio—

52W High$28.53

52W Low$12.56

Avg Volume301K

Open$25.59

Beta1.66

Cash on Hand Financials Revenue

Pulse Biosciences, Inc. (PLSE) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

PLSE · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$80.7M▼ -31.6% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$80.7M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-31.6%

vs prior fiscal year

Latest Quarter

$68.3M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$80.7MCash on Hand

Total Debt$7.5MTotal Debt

Net Cash / Net Debt+$73.2MNet Cash Position

Cash vs Debt Ratio

Cash 91%Pulse Biosciences, Inc. cash as % of market cap: 4.70%% · MCap $2BDebt 9%

Pulse Biosciences, Inc. has a net cash position of $73.2M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$80.7M − $7.5M = +$73.2M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

PLSE annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

PLSE cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$80.7M-31.6%

Dec 31, 2024FY$118.0M+166.1%

Dec 31, 2023FY$44.4M-27.4%

Dec 31, 2022FY$61.1M+113.7%

Dec 31, 2021FY$28.6M+39.8%

PLSE cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

PLSE vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Pulse Biosciences, Inc.YOU

PLSE

$80.7M$2B4.7%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Pulse Biosciences, Inc. (PLSE) cash on hand as of December 31, 2025 is $80.7M, comprising $80.7M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Pulse Biosciences, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Pulse Biosciences, Inc. cash reserves or cash position.

Pulse Biosciences, Inc. annual cash on hand history shows decreased -31.6% in 2025: decreased -31.6% in 2025. Pulse Biosciences, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Pulse Biosciences, Inc. carries total debt of $7.5M against cash of $80.7M, resulting in a net cash position of +$73.2M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

PLSE cash on hand · 5 questions

As of December 31, 2025, Pulse Biosciences, Inc. (PLSE) has $80,735,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $80,735,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $68,319,000. Data sourced from the annual 10-K filing via FMP.

PLSE cash on handPLSE cash reservesPLSE cash 2025how much cash does PLSE have

▸ Source: FMP /balance-sheet-statement · US GAAP · Pulse Biosciences, Inc. · Pulse Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025